Biomarkers to Distinguish Aggressive Cancers from Non-aggressive or Non- progressing cancers
No coordinating investigator defined.
No involved investigator sites defined.
We hypothesize that our novel Biomarker Panel of Auto-antibodies can distinguish aggressive, symptom diagnosed lung cancer from non-aggressive, screen-detected lung cancer.
There are currently no biomarkers annotated for this protocol.
No datasets are currently associated with this protocol.